secwatch.observer — SEC 8-K summary
======================================

Issuer:     MoonLake Immunotherapeutics (MLTX)
CIK:        0001821586
Form:       8-K
Filed at:   2022-03-24T23:59:59+00:00
Accession:  0001213900-22-014894
Event type: debt
Sentiment:  neutral
Materiality: 0.20
Item codes: 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Helix Acquisition Corp. receives $150,000 working capital loan from affiliate Cormorant Asset Management
--------------------------------------------------------------------------------

- Cormorant Asset Management LP, an affiliate of Helix officers, loaned $150,000 for working capital.
- Loan is non-interest bearing, non-convertible, payable upon consummation of a business combination.
- If no business combination occurs, the loan is forgiven except for funds available outside trust account.
- Helix is pursuing a business combination with MoonLake Immunotherapeutics AG as previously disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1821586/000121390022014894/0001213900-22-014894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1821586/000121390022014894/ea157366-8k425_helix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-014894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer